Navigation Links
Europe Hemostasis Testing Market Reviewed in Insightful VPG Report Now Available at MarketPublishers.com
Date:8/14/2013

London, UK (PRWEB) August 14, 2013

Hemostasis testing practice is poised to witness considerable changes in the upcoming years. The factors influencing this change include the increasing cost containment pressures in the developed countries along with the ongoing technological advancements in molecular diagnostics, chromagenic substrates, immunoassays, monoclonal antibodies, computer and laboratory automation.

The demand for novel specific and sensitive hemostasis markers on automated instrumentation is expected to increase substantially in the offing. Hemostasis testing is also predicted to become more standardised, thus, bringing new opportunities for quality control services and products.

Insightful research report “Hemostasis Testing: Granular Analysis of European Market Supplier Shares and Forecasts for 40 Tests France, Germany, Italy, Spain, UK” worked out by Venture Planning Group (VPG) has been recently published by Market Publishers Ltd.

Report Details:

Title: Hemostasis Testing: Granular Analysis of European Market Supplier Shares and Forecasts for 40 Tests France, Germany, Italy, Spain, UK
Published: July, 2013
Price:    US$ 12,800.00
http://marketpublishers.com/report/life_sciences/diagnostics-diseases/hemostasis-testing-granular-analysis-of-european-market-supplier-shares-n-forecasts-4-40-tests-france-germany-italy-spain-uk.html

The report provides a comprehensive overview of the hemostasis testing markets in France, Germany, Italy, Spain and the UK. The study uncovers essential information on the industry performance, identifies and evaluates major market opportunities, presents an insightful market segmentation analysis. The report delves into the competitive landscape, offers vital details on the leading companies and contains data on the sales and shares of the major hemostasis testing instrument and reagent suppliers. In addition, the report discloses test forecasts for the 40 major procedures by market segment and by country.

Market segments covered in the study include: hospitals, commercial/private laboratories, physician offices and ambulatory care centers.

Reasons to Buy:

  •     The report offers an insightful analysis of the five country hemostasis testing markets in Europe (France, Germany, Italy, Spain and the UK).
  •     Vital data on the industry performance helps to get a comprehensive understanding of the current market situation.
  •     The research study allows current market players and potential market entrants to identify and evaluate the emerging market opportunities and turn them into the maximum benefit.
  •     Future forecast is essential for the planning of the effective business, marketing and new product development strategies.
  •     Details on the competitive landscape and the leading companies assist in gaining a competitive advantage in the market and in choosing the potential business partners.
More in-demand research reports by the publisher can be found at VPG page.

Read the full story at http://www.prweb.com/releases/2013/8/prweb11026782.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Quest Diagnostics CE Marks Simplexa™ Test for Cytomegalovirus for Sale in Europe
2. Silence Therapeutics Announces Positive Outcome From Oral Hearing at the European Patent Office
3. The European Union Signs Grant Contract to Fund a 2 Million Euro Biotechnology Research Project Led by Hadassah College Jerusalem
4. Intravenous Remodulin Approved for the Treatment of Pulmonary Arterial Hypertension in Most of the European Union
5. European Multiple Sclerosis Market in Dire Need of Increased Disease Awareness and Treatment Options, Cautions Frost & Sullivan
6. Islet Sciences Announces DiaKine Therapeutics Novel Diabetes, Atherosclerosis Drugs Receives European Patent Protection
7. Chronic Hepatic Diseases Generate High Costs to Europe
8. Tackling the European market of nanoimprint lithography
9. Founder of National Childrens Leukemia Unveiled Non-Embryonic Stem Cell Treatment Promising Cure for Cancer at GIL 2012: Europe
10. Cepheid Announces European Release of Xpert CT/NG and Xpert CT, Delivering Rapid Detection and Differentiation of Chlamydia and Gonorrhoeae
11. Global Markets for Enzymes in Industrial Applications -- Focus on Europe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... MA (PRWEB) , ... December 02, 2016 , ... Robots ... Light Event on December 3rd, 2016. The event, which is held on the ... work with helping Americans with Disabilities back into the workplace. Suitable Technologies is partnering ...
(Date:12/2/2016)... December 2, 2016 The immunohistochemistry (IHC) ... at a CAGR of 7.3% during the forecast period of 2016 ... diagnostic laboratories segment accounted for the largest share of immunohistochemistry (IHC) ... , ... global immunohistochemistry (IHC) market spread across 225 pages, profiling 10 companies ...
(Date:11/30/2016)... ... November 30, 2016 , ... BEI Kimco, a brand ... a flexure design that ensures high alignment accuracy by preventing unwanted shaft rotation. ... suited where extreme precision is required, such as in medical equipment, laboratory instrumentation, ...
(Date:11/30/2016)... , November 30, 2016 ... a few players hold a dominant share in the ... River Laboratories International, Inc., and Merck KGaA, held a ... 2015. Transparency Market Research observes that these companies are ... on development products that are do not require rabbit ...
Breaking Biology Technology:
(Date:11/19/2016)... , Nov. 18, 2016 Securus Technologies, ... solutions for public safety, investigation, corrections and monitoring, announced ... smaller competitor, ICSolutions, to have an independent technology judge ... the most modern high tech/sophisticated telephone calling platform, and ... customers that they do most of what we do ...
(Date:11/15/2016)...  Synthetic Biologics, Inc. (NYSE MKT: SYN), a ... gut microbiome, today announced the pricing of an ... common stock and warrants to purchase 50,000,000 shares ... the public of $1.00 per share and accompanying ... offering, excluding the proceeds, if any from the ...
(Date:6/27/2016)... Research and Markets has announced the addition of the ... The report forecasts the biometrics ... a CAGR of 12.28% during the period 2016-2020. ... with inputs from industry experts. The report covers the market landscape ... includes a discussion of the key vendors operating in this market. ...
Breaking Biology News(10 mins):